Big data can be applied in different ways in different situations spanning operations,
clinical and research environments.
For operational and clinical use it is through “use-cases” that the benefit of big
data can be realised. It is also at this level that the full context can be considered
enabling the operating model changes to be understood alongside the anticipated benefit
and required investment. In parallel research use of big data enables hitherto hidden
insights to be derived through the available data sets and applied analytics capability.
LBDC has developed a comprehensive use-case methodology from initial concepts through
to post deployment benefits realisation management, alongside a clear research benefit
model as set out below.
Use-cases are the specific scaled applications of big data which deliver value …
Use-cases are delivered through robust, scalable algorithms and analytic models which
automate production of predictive analytics such that the insights can be used in
close to real time with patients at the point the predictive insight is needed.
Whilst deployment of big data predictive analytics is the principal source of value
realisation in operational scale, value can also be derived through realisation of
new research opportunities enabled by enhanced data access and analytics capabilities.
As shown in the diagram to the left, the benefit of the LBDC programme can be seen
in tiers from data access, through advanced analytics, to production scale (ie robust
automated models and algorithms). Each build on the former and apply to different
degrees based on the type of use involved.
For all use profiles a common theme is having unified and appropriately governed
access to the collective data sets. Today accessing some of this data can be possible
for research purposes through individual agreement at a point in time but via LBDC
and allied programmes, access to full, real-time data sets opens new research opportunities.
The advanced big data analytics and associated data science capabilities open new
capabilities for all applications, but this does not have to be only route. In some
research situations researchers may wish to manipulate the data directly using other
Recognition of these differences and the common areas of benefit lie at the heart
of the collaboration. The strategy has therefore been developed to cater for each
of these aspects on an equitable basis.
For LBDC to be successful, use-cases must be successful.
To help ensure this is the case the LBDC strategy provides a clear effective, transparent
and robust use case development and deployment methodology. From concept, through
feasibility, to business case stages and beyond, the gated methodology ensures resources
are directed to use cases with greatest merit. The gated portfolio approach also
ensures full visibility to help ensure transparency for all involved.
To progress beyond business case stages, use-cases need to either cost justify (based
on savings, revenue or capacity enhancement) or be sufficiently compelling to attract
external clinical/research funding.
Where business cases are approved to move to implementation, further gated stages
are involved with full portfolio management extending to full benefits realisation
The use-case methodology and wider strategy ensures that LBDC can effectively address
multiple use-cases over time, each with their own business case and associated implementation/project
To learn more please take a look at the LBDC Overview brochure or get in touch using
the links opposite.
USE CASE METHODOLOGY
Ensuring successful realisation of operational and clinical use-cases.
Incubation of an initial portfolio of candidate (ie pre-business case stage) use-cases
is a key theme of the LBDC phase 1 programme.
During this phase, a portfolio of six candidate use-cases are being developed to
business case level. The process of evaluation, feasibility analysis and business
case development in accordance with the gated portfolio approach will ensure the
use-case taken to business case level are robust with compelling business cases.
Currently a use-case to reduce 30 Day Emergency Readmissions has been analysed to
business case level with others currently at concept and feasibility stages.
Please revisit soon to learn more about the portfolio we are developing, or register
for updates and we will keep you posted.
USE CASE PORTFOLIO DEVELOPMENT
Incubating a portfolio of high impact operational and clinical use cases
RESEARCH & ANALYTICS APPLICATIONS
Data, analytics and use-case value for all LBDC Partners
30 DAY EMERGENCY READMISSIONS
HEALTHCARE ACQUIRED INFECTIONS
An operational use-case which helps avoid emergency readmissions through effective
risk profiling and intervention support.
A use case currently at concept level intended to identify those at greatest risk
of HCAI based on multiple data sets such that effective interventions can be taken
to reduce the risk.